Biocon's Biosimilar Blues
The Morning Brief
00:00
Biocon Biologics Acquisition - Biocon Biosimilars to Viatress
Buti asked et skire whether she thought it really was. In many ways, this deal is transformational. It will provide biocon the scale in its bisimilar business. And biocon intends to roll out the ipeo of biocons kiran mazumda shaw call this acquisition transformational.
Play episode from 04:49
Transcript
